Complement activation in circulation and central nervous system after rituximab (anti-CD20) treatment of B-cell lymphoma. [electronic resource]
Producer: 20020917Description: 731-8 p. digitalISSN:- 1042-8194
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Murine-Derived
- Blood Circulation -- immunology
- Blood-Brain Barrier
- Central Nervous System -- immunology
- Cerebrospinal Fluid -- chemistry
- Complement Activation -- drug effects
- Complement C3a -- analogs & derivatives
- Humans
- Lymphoma, B-Cell -- cerebrospinal fluid
- Male
- Middle Aged
- Rituximab
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.